Exponent/$EXPO
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Exponent
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
- Ticker
- $EXPO
- Sector
- Business services
- Primary listing
- NASDAQ
- Employees
- 1,012
- Headquarters
- Menlo Park, United States
- Website
- www.exponent.com
Exponent Metrics
BasicAdvanced
$3.4B
32.25
$2.23
0.70
$1.23
1.73%
Price and volume
Market cap
$3.4B
Beta
0.7
52-week high
$81.95
52-week low
$51.91
Average daily volume
569K
Dividend rate
$1.23
Financial strength
Current ratio
1.977
Quick ratio
1.806
Long term debt to equity
0.256
Total debt to equity
0.28
Dividend payout ratio (TTM)
54.84%
Profitability
EBITDA (TTM)
137.843
Gross margin (TTM)
36.42%
Net profit margin (TTM)
19.71%
Operating margin (TTM)
22.50%
Effective tax rate (TTM)
28.27%
Revenue per employee (TTM)
$560,000
Management effectiveness
Return on assets (TTM)
11.29%
Return on equity (TTM)
31.20%
Valuation
Price to earnings (TTM)
32.247
Price to revenue (TTM)
6.325
Price to book
11.83
Price to tangible book (TTM)
12.2
Price to free cash flow (TTM)
33.042
Free cash flow yield (TTM)
3.03%
Free cash flow per share (TTM)
2.175
Dividend yield (TTM)
1.71%
Forward dividend yield
1.73%
Growth
Revenue change (TTM)
9.24%
Earnings per share change (TTM)
11.95%
3-year revenue growth (CAGR)
5.27%
10-year revenue growth (CAGR)
6.70%
3-year earnings per share growth (CAGR)
4.21%
10-year earnings per share growth (CAGR)
9.80%
3-year dividend per share growth (CAGR)
6.85%
10-year dividend per share growth (CAGR)
13.97%
What the Analysts think about Exponent
Analyst ratings (Buy, Hold, Sell) for Exponent stock.
Analyst projections of the future price of Exponent stock.
Bulls say / Bears say
Net revenue rose 12% in the second quarter, with demand spanning AI-enabled product research, utility risk work and reactive disputes. This mix of proactive and reactive projects gives Exponent several sources of work. (Exponent)
Management raised its 2026 forecast to 9%–10% net revenue growth and a 27.8%–28.1% EBITDA margin. The higher outlook signals confidence that recent demand can support continued growth and strong profitability. (Exponent)
Utilisation improved to 74% from 72% a year earlier, while billable hours rose 8% and realised rates increased about 4%. These gains helped lift the quarter’s EBITDA margin to 28.7% from 27.8%. (The Motley Fool)
One user-research study accounted for about 4% of second-quarter net revenue, and management expected its contribution to ease to around 2% for the rest of the year. Utilisation also benefited from this work, so a slowdown could leave a gap to fill. (The Motley Fool)
One client accounted for about 11% of second-quarter revenue, creating some exposure if that client’s work falls away. No client exceeded 10% of revenue across the first half, but the quarterly figure shows that reliance can vary over time. (Last10K)
General and administrative costs rose 20% in the second quarter, partly because of higher recruiting and travel costs. If such expenses keep rising faster than revenue, they could weigh on margins. (The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.
Exponent Financial Performance
Revenues and expenses
Exponent Earnings Performance
Company profitability
Upcoming events
No upcoming events
Exponent News
AllArticlesVideos
Funds containing Exponent
AllEURGBPUSD
Fund name | Fund size | $EXPO weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.12% |
SPDR Russell 2000 US Small Cap£R2SC | £4.1B | 0.12% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.3B | 0.10% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.10% |
SPDR MSCI All Country World IM€SPYI | €7.5B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.